These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3288652)

  • 1. Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients.
    Jørgensen JO; Flyvbjerg A; Lauritzen T; Alberti KG; Orskov H; Christiansen JS
    J Clin Endocrinol Metab; 1988 Jul; 67(1):36-40. PubMed ID: 3288652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices.
    Jørgensen JO; Møller N; Lauritzen T; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1616-23. PubMed ID: 2189886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.
    Jørgensen JO; Møller N; Lauritzen T; Alberti KG; Orskov H; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jan; 70(1):207-14. PubMed ID: 2294131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers.
    de Boer H; Blok GJ; Popp-Snijders C; Stuurman L; Baxter RC; van der Veen E
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1371-7. PubMed ID: 8636336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of octreotide on insulin-like growth factor I and metabolic indices in growth hormone-treated growth hormone-deficient patients.
    Laursen T; Jørgensen JO; Orskov H; Møller J; Harris AG; Christiansen JS
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):399-408. PubMed ID: 7506470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response studies on the metabolic effects of a growth hormone pulse in humans.
    Møller N; Schmitz O; Pørksen N; Møller J; Jørgensen JO
    Metabolism; 1992 Feb; 41(2):172-5. PubMed ID: 1736039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.
    Laursen T; Jørgensen JO; Christiansen JS
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):337-43. PubMed ID: 7525120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults.
    Yuen K; Ong K; Husbands S; Chatelain P; Fryklund L; Gluckman P; Ranke M; Cook D; Rosenfeld R; Wass J; Dunger D
    J Clin Endocrinol Metab; 2002 May; 87(5):1989-95. PubMed ID: 11994330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback.
    Chapman IM; Hartman ML; Pezzoli SS; Harrell FE; Hintz RL; Alberti KG; Thorner MO
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2996-3004. PubMed ID: 9284733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse.
    Bianda TL; Hussain MA; Keller A; Glatz Y; Schmitz O; Christiansen JS; Alberti KG; Froesch ER
    Diabetologia; 1996 Aug; 39(8):961-9. PubMed ID: 8858219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I and growth hormone have different effects on serum lipoproteins and secretion of lipoproteins from cultured rat hepatocytes.
    Sjöberg A; Oscarsson J; Olofsson SO; Edén S
    Endocrinology; 1994 Oct; 135(4):1415-21. PubMed ID: 7925103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
    Böni-Schnetzler M; Hauri C; Zapf J
    Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters.
    Møller J; Jørgensen JO; Lauersen T; Frystyk J; Naeraa RW; Orskov H; Christiansen JS
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):403-8. PubMed ID: 7507009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a growth hormone pulse on total and forearm substrate fluxes in humans.
    Møller N; Jørgensen JO; Schmitz O; Møller J; Christiansen J; Alberti KG; Orskov H
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E86-91. PubMed ID: 2405702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
    McConnell EM; Atkinson AB; Ennis C; Hadden DR; McCance DR; Sheridan B; Bell PM
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
    de Muinck Keizer-Schrama SM; Rikken B; Wynne HJ; Hokken-Koelega AC; Wit JM; Bot A; Drop SL
    J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolic effects of high-dose growth hormone administration in healthy adult men.
    Tanaka T; Seino Y; Fujieda K; Igarashi Y; Yokoya S; Tachibana K; Ogawa Y
    Endocr J; 1999 Aug; 46(4):605-12. PubMed ID: 10580755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ; Plöckinger U
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.